Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joerg Frei is active.

Publication


Featured researches published by Joerg Frei.


Biophysical Journal | 2003

New cationic lipids form channel-like pores in phospholipid bilayers.

Alexandr Chanturiya; Jingping Yang; Puthupparampil V. Scaria; Jaroslav Stanek; Joerg Frei; Helmut Mett; Martin C. Woodle

Two representatives of a new class of cationic lipids were found to have high pore-forming activity in planar bilayer membranes. These molecules, called BHHD-TADC and BHTD-TADC, have qualitatively similar effects on phospholipid membranes. Addition of 2.5-5 micro M of either of them to the membrane bathing solutions resulted in formation of long-lived anion-selective pores with conductance in the range 0.1-2 nS in 0.1 M KCl. Pore formation was found to be dependent on the potential applied to the membrane. When negative potential was applied to membrane at the side of addition, the rate of pore formation was much lower compared to when the positive potential was applied. Dependence of pore formation on compound concentration was highly nonlinear, indicating that this process requires assembly of molecules in the membrane. Addition of any of these compounds on both sides of the membrane increased the efficiency of pore formation by one to two orders of magnitude. Pore formation was strongly pH dependent. Although pores were formed with high efficiency at pH 6.5, only occasional fluctuations of membrane conductance were observed at pH 7.5. Possible mechanisms of new compounds biological activity are discussed.


Journal of Medicinal Chemistry | 1997

Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors : 4-(phenylamino)pyrazolo[3,4-d]pyrimidines

Peter Traxler; Guido Bold; Joerg Frei; Marc Lang; Nicholas B. Lydon; Helmut Mett; Elisabeth Buchdunger; Thomas J. Meyer; Marcel Mueller; Pascal Furet


Archive | 2000

Phthalazine derivatives for treating inflammatory diseases

Guido Bold; King Janet Dawson; Joerg Frei; Richard Heng; Paul W. Manley; Bernhard Wietfeld; Jeanette Marjorie Wood


Journal of Medicinal Chemistry | 1992

2-Substituted 3-(aminooxy) propanamines as inhibitors of ornithine decarboxylase : synthesis and biological activity

Jaroslav Stanek; Joerg Frei; Helmut Mett; Peter Schneider; Urs Regenass


Archive | 2000

Novel colloid synthetic vectors for gene therapy

Martin C. Woodle; Cheng Cheng; Puthupparampil V. Scaria; Kas Subramanian; Richard Titmas; Jingping Yang; Joerg Frei; Helmut Mett; Jaroslav Stanek


Archive | 1970

Neue Pyrimidinderivate und Verfahren zu deren Herstellung

Ernst Schweizer; Joerg Frei; Atso Dr Ilvespaeae


Archive | 1994

Ornithine decarboxylase inhibiting cyclic aminooxy compounds

Joerg Frei; Jaroslav Stanek


Archive | 2006

DERIVADOS DE FTALAZINA PARA TRATAR DOENCAS INFLAMATORIAS

Bold Guido; Janet Dawson King; Joerg Frei; Richard Heng; William Manley Paul; Bernhard Wietfeld; Marjorie Wood Jeanette


Archive | 2000

Phthalazine derivatives for the treatment of inflammatory diseases

Guido Bold; King Janet Dawson; Joerg Frei; Richard Heng; William Paul Manley; Bernhard Wietfeld; Marjorie Wood


Archive | 1997

Pyrimiderivate und verfahren zu ihrer herstellung

Guido Bold; Joerg Frei; Marc Lang; Peter Traxler

Collaboration


Dive into the Joerg Frei's collaboration.

Researchain Logo
Decentralizing Knowledge